Previous studies show that feedback inhibition of
bile acid production by
bile acids is mediated by multiple mechanisms, including activation of
pregnane X receptor (PXR). Consistent with these studies, the
antibiotic rifampicin, a
ligand for human PXR, reduces hepatic
bile acid levels in
cholestasis patients. To delineate the mechanisms underlying PXR-mediated suppression of
bile acid biosynthesis, we examined the functional cross-talk between human PXR and HNF-4, a key hepatic activator of genes involved in
bile acid biosynthesis including the
cholesterol 7-alpha
hydroxylase (CYP7A1) and
sterol 12-alpha
hydroxylase (
CYP8B1) genes. Treatment with
rifampicin resulted in repression of endogenous human CYP7A1 expression in HepG2 cells that was reversed by PXR
small interfering RNA. The coactivator PGC-1 enhanced transcriptional activity of HNF-4, and this enhancement was suppressed by
rifampicin-activated PXR. Endogenous PGC-1 from mouse
liver extracts bound to PXR, and recombinant PGC-1 directly interacted with both PXR and HNF-4 in vitro.
Rifampicin-dependent interaction of PXR with PGC-1 was shown in cells by coimmunoprecipitation, and intranuclear localization studies using confocal microscopy provided further evidence for this interaction. In
chromatin immunoprecipitation studies,
rifampicin treatment did not inhibit HNF-4 binding to the native promoters of CYP7A1 and
CYP8B1 but resulted in dissociation of PGC-1 and concomitant gene repression. Most interestingly, these
rifampicin effects were also observed in the
phosphoenolpyruvate carboxykinase gene that contains a functional HNF-4-binding site and is central to hepatic gluconeogenesis. Our study suggests that
ligand-activated PXR interferes with HNF-4 signaling by targeting the common coactivator PGC-1, which underlies physiologically relevant inhibitory cross-talk between
drug metabolism and
cholesterol/
glucose metabolism.